Human ehrlichiosis in transplant recipients

American Journal of Transplantation

Volumn 7, Issue 6, 2007, Pages 1641-1647

  Thomas, L D ^a   Hongo, I ^a   Bloch, K C ^a   Tang, Y W ^a   Dummer, S ^a,b  

^a VANDERBILT UNIVERSITY   (United States)

^b Vanderbilt University Transplant Center   (United States)

Author keywords

Ehrlichiosis; Immunocompromised host; Tick borne disease; Transplant infections

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN A; DOXYCYCLINE; LIVER ENZYME; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RAPAMYCIN; RHODOMYCIN A; SULFONAMIDE; TACROLIMUS;

ACUTE GRAFT REJECTION; ADOLESCENT; ADULT; AGED; ARTICLE; CARDIAC GRAFT REJECTION; CLINICAL FEATURE; COMPARATIVE STUDY; CONGENITAL HYPOTHYROIDISM; CONTROLLED STUDY; DEATH; DEMOGRAPHY; EHRLICHIA; EHRLICHIA CHAFFEENSIS; EHRLICHIOSIS; FEMALE; GRAFT RECIPIENT; HEART GRAFT; HOSPITAL; HUMAN; IMMUNOCOMPETENT CELL; IMMUNOSUPPRESSIVE TREATMENT; INFECTION PREVENTION; KIDNEY DYSFUNCTION; KIDNEY GRAFT REJECTION; LEUKOPENIA; LIVER GRAFT REJECTION; LUNG GRAFT REJECTION; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEASONAL VARIATION; SERODIAGNOSIS; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME; UNITED STATES;

ADOLESCENT; ADULT; AGED; ANIMALS; EHRLICHIA; EHRLICHIOSIS; FEMALE; HEART TRANSPLANTATION; HUMANS; IMMUNOCOMPETENCE; IMMUNOSUPPRESSION; KIDNEY TRANSPLANTATION; LIVER FUNCTION TESTS; LIVER TRANSPLANTATION; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDIES; TENNESSEE;

EID: 34248670152     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2007.01821.x     Document Type: Article

References (25)

1. Safdar N, Love RB, Maki DG. Severe Ehrlichia chaffeensis infection in a lung transplant recipient: A review of ehrlichiosis in the immunmocompromised patient. Emerg Infect Dis 2002 8 : 320 323.
2. Buller RS, Arens M, Hmiel SP et al. Ehrlichia ewingii, a newly recognized agent of human ehrlichiosis. N Engl J Med 1999 341 : 148 155.
3. Paddock CD, Folk SM, Shore GM et al. Infections with Ehrlichia chaffeensis and Ehrlichia ewingii in persons coinfected with human immunodeficiency virus. Clin Infect Dis 2001 33 : 1586 1594.
4. Tan HP, Dumler JS, Maley WR et al. Human monocytic ehrlichiosis: An emerging pathogen in transplantation. Transplantation 2001 71 : 1678 1680.
5. Antony SJ, Dummer JS, Hunter E. Human ehrlichiosis in a liver transplant recipient. Transplantation 1995 60 : 879 881.
6. Liddell AM, Sumner JW, Paddock CD et al. Reinfection with Ehrlichia chaffeensis in a liver transplant recipient. Clin Infect Dis 2002 34 : 1644 1647.
7. Everett ED, Evans KA, Henry RB, McDonald G. Human ehrlichiosis in adults after tick exposure: Diagnosis using polymerase chain reaction. Ann Intern Med 1994 120 : 730 735.
8. Olano JP, Hogrefe W, Seaton B, Walker DH. Clinical manifestations, epidemiology, and laboratory diagnosis of human monocytotropic ehrlichiosis in a commercial laboratory setting. Clin Diagn Lab Immunol 2003 10 : 891 896.
9. Talbot TR, Comer JA, Bloch KC. Ehrlichia chaffeensis infections among HIV-infected patients in a human monocytic ehrlichiosis-endemic area. Emerg Inf Dis 2003 9 : 1123 1127.
10. Yevich SJ, Sanchez JL, DeFraites RF et al. Seroepidemiology of infections due to spotted fever group rickettsiae and Ehrlichia species in military personnel exposed in areas of the United States where such infections are endemic. J Infect Dis 1995 171 : 1266 1273.
11. Doyle CK, Labruna MB, Breitschwerdt EB et al. Detection of medically important Ehrlichia by quantitative multicolor TaqMan real-time polymerase chain reaction of the dsb gene. J Mol Diag 2005 7 : 504 510.
12. Sefers SE, Rickmyre J, Blackman A, Li H, Edwards K, Tang YW. QIAamp MinElute virus kit effectively extracts viral nucleic acids from cerebrospinal fluids and nasopharyngeal swabs. J Clin Virol 2006 35 : 141 146.
13. Tang YW, Rys PN, Rudledge BJ, Mitchell PS, Smith TF, Persing DH. Comparative evaluation of colorimetric microtiter plate systems for detection of herpes simplex virus in cerebrospinal fluid. J Clin Microbiol 1998 36 : 2714 2717.
14. Maeda K, Markowitz N, Hawley RC, Ristic M, Cox D, McDade JE. Human infection with Ehrlichia canis, a leukocytic rickettsia. N Engl J Med 1987 316 : 853 856.
15. http://www.cdc.gov/ncidod/dvrd/ehrlichia/Index.htm (Accessed October 2006).
16. Fishbein DB, Dawson JE, Robinson LE. Human ehrlichiosis in the United States, 1985 to 1990. Ann Intern med 1994 120 : 736 743.
17. Carstens J, Andersen HK, Spencer E, Madsen M. Cytomegalovirus infection in renal transplant recipients. Transpl Infect Dis 2006 8 : 203 212.
18. Limaye AP, Bakthavatsalam R, Kim HW et al. Impact of cytomegalovirus in organ transplant recipients in the era of antiviral prophylaxis. Transplantation 2006 81 : 1645 1652.
19. Peters TR, Edwards KM, Standaert SM. Severe ehrlichiosis in an adolescent taking trimethoprim-sulfamethoxazole. Pediatr Infect Dis J 2000 19 : 170 172.
20. Brantley RK. Trimethoprim-sulfamethoxazole and fulminant ehrlichiosis. Pediatr Infect Dis J 2001 20 : 231.
21. Steigman AJ. Rocky Mountain spotted fever and the avoidance of sulfonamides. J Pediatr 1977 91 : 163 164.
22. Dawson JE, Fishbein DB, Eng TR, Redus MA, Greene NR. Diagnosis of human ehrlichiosis with the indirect fluorescent antibody test: Kinetics and specificity. J Infect Dis 1990 162 : 91 95.
23. Stone JH, Dierberg K, Aram G, Dumler JS. Human monocytic ehrlichiosis. JAMA 2004 292 : 2263 2270.
24. Lee EH, Rikihisa Y. Anti-Ehrlichia chaffeensis antibody complexed with E. chaffeensis induces potent proinflammatory cytokine mRNA expression in human monocytes through sustained reduction of IκB-α and activation of NF-κB. Infect Immun 1997 65 : 2890 2897.
25. Lee EH, Rikihisa Y. Absence of tumor necrosis factor alpha, interleukin-6 (IL-6), and granulocyte-macrophage colony-stimulating factor expression but presence of IL-1β, IL-8, and IL-10 expression in human monocytes exposed to viable or killed Ehrlichia chaffeensis. Infect Immun 1996 64 : 4211 4219.